Ki Summary

Reaction Details

Report a problem with these data

Target

P2X purinoceptor 3

Ligand

BDBM266955

Substrate/Competitor

n/a

Meas. Tech.

Human P2X3 Receptor Inhibition Assay

7.5±n/a

IC50

1.000±n/a nM

Comments

extracted

Citation

Kai, H; Horiguchi, T; Asahi, K; Fujii, Y Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same US Patent US9718790 Publication Date 8/1/2017

More Info.:

Get all data from this article, Assay Method

P2X purinoceptor 3

Name:

P2X purinoceptor 3

Synonyms:

Type:

Protein

Mol. Mass.:

44292.02

Organism:

Homo sapiens (Human)

Description:

P56373

Residue:

397

Sequence:

MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSV
VTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDS
QCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIR
FPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLG
IKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKA
FGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEE
VNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH

BDBM266955

n/a

Name

BDBM266955

Synonyms:

US9718790, I-2701

Type

Small organic molecule

Emp. Form.

C25H30N6O5

Mol. Mass.

494.5429

SMILES

CCn1c(=O)[nH]\c(=N/c2ccc(Oc3ccc(nn3)C(=O)OC)cc2)n(C[C@H]2CC[C@H](C)CC2)c1=O |r,wU:27.28,wD:30.32,(6,-1.15,;4.67,-.38,;3.33,-1.15,;2,-.38,;2,1.15,;.67,-1.15,;.67,-2.69,;-.67,-3.47,;-2,-2.69,;-3.33,-3.47,;-4.67,-2.69,;-4.67,-1.15,;-6,-.38,;-6,1.15,;-7.34,1.93,;-7.34,3.47,;-6,4.23,;-4.67,3.47,;-4.67,1.93,;-6,5.78,;-7.34,6.54,;-4.67,6.54,;-4.67,8.08,;-3.33,-.38,;-2,-1.15,;2,-3.47,;2,-5,;3.33,-5.78,;4.67,-5,;6,-5.78,;6,-7.31,;7.34,-8.08,;4.67,-8.08,;3.33,-7.31,;3.33,-2.69,;4.67,-3.47,)|

Structure